Thomas Pabst
Impact in
- Hematology top 0.1%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
- Genetics top 0.5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 158
- Acute Myeloid Leukemia Research 105
- Multiple Myeloma Research and Treatments 60
- Hematopoietic Stem Cell Transplantation 43
- Oncology 92
- CAR-T cell therapy research 41
- Co-authors
- Beatrice U. Mueller (30 shared papers)Ulrike Bacher (99 shared papers)Gert Jan Ossenkoppele (15 shared papers)Bob Löwenberg (16 shared papers)Katja Seipel (50 shared papers)Johan A. Maertens (12 shared papers)Bart J. Biemond (10 shared papers)Edo Vellenga (6 shared papers)
- Journals
- Blood (28 papers)Cancers (21 papers)Bone Marrow Transplantation (18 papers)Hematological Oncology (18 papers)Blood Advances (11 papers)
- Partner nations
- SwitzerlandGermanyNetherlands
In The Last Decade
Thomas Pabst
248 papers receiving 8.4k citations
Thomas Pabst's Hit Papers
Peers
Comparison fields: 5 of 111
- Hematology 5.1k
- Genetics 1.3k
- Pathology and Forensic Medicine 1.3k
- Oncology 1.9k
- Cancer Research 700
Countries citing papers authored by Thomas Pabst
This map shows the geographic impact of Thomas Pabst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Pabst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Pabst more than expected).
Fields of papers citing papers by Thomas Pabst
This network shows the impact of papers produced by Thomas Pabst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Pabst. The network helps show where Thomas Pabst may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Pabst, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 266 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia Hit paper breakdown → | 2009 | 698 |
| 2 | Molecular Minimal Residual Disease in Acute Myeloid Leukemia Hit paper breakdown → | 2018 | 646 |
| 3 | 2013 | 382 | |
| 4 | 2011 | 341 | |
| 5 | 2010 | 330 | |
| 6 | 2017 | 270 | |
| 7 | Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome Hit paper breakdown → | 2022 | 224 |
| 8 | 2017 | 217 | |
| 9 | 2008 | 215 | |
| 10 | 2010 | 209 | |
| 11 | 2014 | 179 | |
| 12 | 2005 | 170 | |
| 13 | 2018 | 166 | |
| 14 | 2015 | 151 | |
| 15 | 2014 | 143 | |
| 16 | 2009 | 142 | |
| 17 | 2007 | 130 | |
| 18 | 2012 | 121 | |
| 19 | 2014 | 115 | |
| 20 | 2010 | 113 |
About Thomas Pabst
Thomas Pabst is a scholar working on Hematology, Oncology, Genetics, Pathology and Forensic Medicine and Molecular Biology, having authored 266 papers that have together received 8.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (105 papers), Multiple Myeloma Research and Treatments (60 papers), Hematopoietic Stem Cell Transplantation (43 papers), Lymphoma Diagnosis and Treatment (42 papers), CAR-T cell therapy research (41 papers), Protein Degradation and Inhibitors (31 papers), Acute Lymphoblastic Leukemia research (22 papers) and Retinoids in leukemia and cellular processes (16 papers). The work is most often cited by research in Hematology (5.1k citations), Genetics (1.3k citations), Pathology and Forensic Medicine (1.3k citations), Oncology (1.9k citations) and Cancer Research (700 citations). Thomas Pabst has collaborated with scholars based in Switzerland, Germany and Netherlands. Frequent co-authors include Beatrice U. Mueller, Ulrike Bacher, Gert Jan Ossenkoppele, Bob Löwenberg, Katja Seipel, Johan A. Maertens, Bart J. Biemond, Edo Vellenga, Leo F. Verdonck and Harry C. Schouten. Their work appears in journals such as Blood, Cancers, Bone Marrow Transplantation, Hematological Oncology and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.